These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Screening for adverse drug reactions. Bulpitt CJ Br J Hosp Med; 1977 Oct; 18(4):329, 333-4. PubMed ID: 912156 [No Abstract] [Full Text] [Related]
4. Effects of geriatric evaluation and management on adverse drug reactions and suboptimal prescribing in the frail elderly. Schmader KE; Hanlon JT; Pieper CF; Sloane R; Ruby CM; Twersky J; Francis SD; Branch LG; Lindblad CI; Artz M; Weinberger M; Feussner JR; Cohen HJ Am J Med; 2004 Mar; 116(6):394-401. PubMed ID: 15006588 [TBL] [Abstract][Full Text] [Related]
5. [From suspected adverse reactions to verified adverse reactions - contribution of epidemiology]. Greiser E Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1540-50. PubMed ID: 417498 [No Abstract] [Full Text] [Related]
6. Adverse drug reactions as a cause for admissions to a department of internal medicine. Mjörndal T; Boman MD; Hägg S; Bäckström M; Wiholm BE; Wahlin A; Dahlqvist R Pharmacoepidemiol Drug Saf; 2002; 11(1):65-72. PubMed ID: 11998554 [TBL] [Abstract][Full Text] [Related]
7. Causality assessment of adverse drug reactions: comparison of the results obtained from published decisional algorithms and from the evaluations of an expert panel. Macedo AF; Marques FB; Ribeiro CF; Teixeira F Pharmacoepidemiol Drug Saf; 2005 Dec; 14(12):885-90. PubMed ID: 16059869 [TBL] [Abstract][Full Text] [Related]
8. Patient reporting of suspected adverse drug reactions: a review of published literature and international experience. Blenkinsopp A; Wilkie P; Wang M; Routledge PA Br J Clin Pharmacol; 2007 Feb; 63(2):148-56. PubMed ID: 17274788 [TBL] [Abstract][Full Text] [Related]
13. Adverse drug reactions in a developing country: problems encountered in a surveillance programme in a Nigerian hospital. Okonkwo PO; Egere JU; Ogbuokiri JE Cent Afr J Med; 1980 Nov; 26(11):239-42. PubMed ID: 7471190 [No Abstract] [Full Text] [Related]
14. Veterinary pharmacovigilance. Part 5. Causality and expectedness. Woodward KN J Vet Pharmacol Ther; 2005 Apr; 28(2):203-11. PubMed ID: 15842308 [TBL] [Abstract][Full Text] [Related]
15. Detection of adverse drug reactions in a clinical trial using two types of questioning. Wallin J; Sjövall J Clin Ther; 1981; 3(6):450-2. PubMed ID: 7020939 [TBL] [Abstract][Full Text] [Related]
16. [Adverse effects of drugs. Compiled and evaluated by the Committee on Drugs]. Ochsenfahrt H Fortschr Med; 1984 Apr; 102(13):355-60. PubMed ID: 6724463 [TBL] [Abstract][Full Text] [Related]
17. Adverse drug reactions. Duffull S N Z Med J; 1990 Oct; 103(899):493. PubMed ID: 2216142 [No Abstract] [Full Text] [Related]
18. Adverse drug effects: evaluation of four secondary reference sources. Lyon RA Hosp Formul; 1985 Mar; 20(3):315-7, 320-1. PubMed ID: 10270307 [TBL] [Abstract][Full Text] [Related]
19. Adverse drug reactions and avalanches: life at the edge of chaos. Frattarelli DA J Clin Pharmacol; 2005 Aug; 45(8):866-71. PubMed ID: 16027396 [TBL] [Abstract][Full Text] [Related]
20. A quantitative approach of using genetic algorithm in designing a probability scoring system of an adverse drug reaction assessment system. Koh Y; Yap CW; Li SC Int J Med Inform; 2008 Jun; 77(6):421-30. PubMed ID: 17921048 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]